These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27549781)

  • 1. Demographic Differences in Disruptive Mood Dysregulation Disorder Symptoms in ADHD, Autism, and General Population Samples.
    Mayes SD; Calhoun SL; Waxmonsky JG; Kokotovich C; Baweja R; Lockridge R; Bixler EO
    J Atten Disord; 2019 Jun; 23(8):849-858. PubMed ID: 27549781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruptive Mood Dysregulation Disorder Symptoms and Association with Oppositional Defiant and Other Disorders in a General Population Child Sample.
    Mayes SD; Waxmonsky JD; Calhoun SL; Bixler EO
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):101-6. PubMed ID: 26745442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruptive Mood Dysregulation Disorder in a Community Mental Health Clinic: Prevalence, Comorbidity and Correlates.
    Freeman AJ; Youngstrom EA; Youngstrom JK; Findling RL
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):123-30. PubMed ID: 26745325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity and correlates of disruptive mood dysregulation disorder in 6-8-year-old children with ADHD.
    Mulraney M; Schilpzand EJ; Hazell P; Nicholson JM; Anderson V; Efron D; Silk TJ; Sciberras E
    Eur Child Adolesc Psychiatry; 2016 Mar; 25(3):321-30. PubMed ID: 26122202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Disruptive Mood Dysregulation Disorder Symptoms (Irritable-Angry Mood and Temper Outbursts) Throughout Childhood and Adolescence in a General Population Sample.
    Mayes SD; Mathiowetz C; Kokotovich C; Waxmonsky J; Baweja R; Calhoun SL; Bixler EO
    J Abnorm Child Psychol; 2015 Nov; 43(8):1543-1549. PubMed ID: 26004122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focus on Disruptive Mood Dysregulation Disorder: A review of the literature.
    Bruno A; Celebre L; Torre G; Pandolfo G; Mento C; Cedro C; Zoccali RA; Muscatello MRA
    Psychiatry Res; 2019 Sep; 279():323-330. PubMed ID: 31164249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Executive function in children with disruptive mood dysregulation disorder compared to attention-deficit/hyperactivity disorder and oppositional defiant disorder, and in children with different irritability levels.
    Brænden A; Coldevin M; Zeiner P; Stubberud J; Melinder A
    Eur Child Adolesc Psychiatry; 2024 Jan; 33(1):115-125. PubMed ID: 36680626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence Rate and Course of Symptoms of Disruptive Mood Dysregulation Disorder (DMDD).
    Grau K; Plener PL; Hohmann S; Fegert JM; Brähler E; Straub J
    Z Kinder Jugendpsychiatr Psychother; 2018 Jan; 46(1):29-38. PubMed ID: 29067863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruptive Mood Dysregulation Disorder (DMDD): An RDoC perspective.
    Meyers E; DeSerisy M; Roy AK
    J Affect Disord; 2017 Jul; 216():117-122. PubMed ID: 27554606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of disruptive mood dysregulation disorder in children with attention-deficit/hyperactivity disorder.
    Mulraney M; Silk TJ; Gulenc A; Efron D; Hazell P; Sciberras E
    J Affect Disord; 2021 Jan; 278():502-505. PubMed ID: 33017677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School.
    Baweja R; Belin PJ; Humphrey HH; Babocsai L; Pariseau ME; Waschbusch DA; Hoffman MT; Akinnusi OO; Haak JL; Pelham WE; Waxmonsky JG
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):154-63. PubMed ID: 26771437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between Disruptive Mood Dysregulation Disorder symptoms and sleep problems in children with and without ADHD.
    Waxmonsky JG; Mayes SD; Calhoun SL; Fernandez-Mendoza J; Waschbusch DA; Bendixsen BH; Bixler EO
    Sleep Med; 2017 Sep; 37():180-186. PubMed ID: 28899532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological mechanisms of social difficulties in disruptive mood dysregulation disorder versus oppositional defiant disorder.
    Brænden A; Coldevin M; Zeiner P; Stubberud J; Melinder A
    Child Neuropsychol; 2024 Apr; 30(3):402-424. PubMed ID: 37106502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DSM-5 disruptive mood dysregulation disorder: correlates and predictors in young children.
    Dougherty LR; Smith VC; Bufferd SJ; Carlson GA; Stringaris A; Leibenluft E; Klein DN
    Psychol Med; 2014 Aug; 44(11):2339-50. PubMed ID: 24443797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in diagnosis of bipolar and disruptive mood dysregulation disorders in children and youth.
    Le J; Feygin Y; Creel L; Lohr WD; Jones VF; Williams PG; Myers JA; Pasquenza N; Davis DW
    J Affect Disord; 2020 Mar; 264():242-248. PubMed ID: 32056757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Emotional Lability Distinct From "Angry/Irritable Mood," "Negative Affect," or Other Subdimensions of Oppositional Defiant Disorder in Children With ADHD?
    Liu L; Chen W; Vitoratou S; Sun L; Yu X; Hagger-Johnson G; Wu Z; Yang L; Qian Q; Wang Y
    J Atten Disord; 2019 Jun; 23(8):859-868. PubMed ID: 26842831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temper Loss and Persistent Irritability in Preschoolers: Implications for Diagnosing Disruptive Mood Dysregulation Disorder in Early Childhood.
    Martin SE; Hunt JI; Mernick LR; DeMarco M; Hunter HL; Coutinho MT; Boekamp JR
    Child Psychiatry Hum Dev; 2017 Jun; 48(3):498-508. PubMed ID: 27510439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Defining the Clinical Boundary of Disruptive Mood Dysregulation Disorder Symptoms in Youth.
    Stoddard J; Wiggins JL; Wakschlag LS
    J Am Acad Child Adolesc Psychiatry; 2021 Feb; 60(2):216-218. PubMed ID: 33359030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder.
    Winters DE; Fukui S; Leibenluft E; Hulvershorn LA
    J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):298-305. PubMed ID: 29708762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative Frequency of Psychiatric, Neurodevelopmental, and Somatic Symptoms as Reported by Mothers of Children with Autism Compared with ADHD and Typical  Samples.
    Mayes SD; Calhoun SL; Baweja R; Waschbusch DA
    J Autism Dev Disord; 2021 Jul; 51(7):2297-2307. PubMed ID: 32949313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.